Biotech offers both investment opportunities and groundbreaking advancements in medicine, making it an exciting sector for investors. Biotech stocks benefit from cutting-edge technologies and consistent revenue streams, even during global…
Amid a biotech landscape in flux, Apriori Bio shifts focus, reducing its workforce by 15 to enhance vaccine development. The company transitions from platform expansion to accelerating its pipeline, leveraging…
Akeso introduces ivonescimab, a groundbreaking cancer drug, extending patient survival without disease progression to over 11 months, outperforming Keytruda's 5.8 months. Ivonescimab's success represents a significant advancement in cancer treatment,…
China's biotech scene is rapidly developing, with significant advancements seen in cities like Hangzhou and Beijing, challenging Western pharmaceutical strongholds. The return of "sea turtles"—internationally trained Chinese scientists—has been pivotal…
The partnership between Emergent BioSolutions and Rocketvax drives innovation in global health, focusing on vaccine development for infectious diseases, cancer, and autoimmune disorders. Rocketvax's live-attenuated nasal spray SARS-CoV-2 vaccine exhibits…
Flagship Pioneering unveils Lila Sciences, a biotech company focused on autonomous AI-driven laboratories with $200 million in seed funding. Aiming to transform scientific research, Lila's AI platform autonomously designs and…
Oncolytics Biotech Inc. faces financial challenges, reporting a Q4 2024 net loss of $8 million and declining cash reserves. The company’s flagship oncolytic virus, pelareorep, shows promise in cancer therapeutics,…
Tevogen Bio leverages AI to revolutionize precision medicine, merging proprietary datasets with generative AI models. The company's approach focuses on transforming therapeutic applications from generalized to highly personalized treatments. AI's…
Wisconsin is emerging as a hotspot for biotechnology, driven by both established companies and new ventures. Epic Systems in Verona leads in healthcare technology, creating networks that connect patients and…
Aardvark Therapeutics launches its IPO, marking the first life science IPO of 2025 in San Diego, with its stock starting at $16 on Nasdaq. The company focuses on small molecule…